Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 52817-223

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 52817-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Sertraline Hydrochloride, showing the molecular arrangement with two benzene rings, one bearing two chlorine substituents, and a methylamino hydrochloride group attached to the cyclohexane ring.*

FDA Label Image

150-mg-label (150 mg Label)

Label for Sertraline Hydrochloride Tablets USP, 150 mg, film-coated oral tablets. The label states each tablet contains sertraline hydrochloride equivalent to 150 mg sertraline. Manufactured for TruPharma, LLC, Tampa, FL. The label includes storage instructions, a barcode, and a quantity of 90 tablets.*

FDA Label Image

200-mg-label (200 mg Label)

Label for Sertraline Hydrochloride Tablets, USP, 200 mg film-coated tablets by TruPharma, LLC. The label includes drug strength, a note to dispense the medication guide, NDC 52817-224-90, and packaging for 90 tablets. Storage instructions and manufacturer information (Made in India) are also visible, along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.